Kristine B. Zitelli, MD

Squamous Cell Carcinoma of the Lip Associated With Adalimumab Therapy for Ankylosing Spondylitis: A Case Report and Review of TNF-α Inhibitors and Cutaneous Carcinoma Risk

Publish date: July 3, 2013

Adalimumab is an anti–tumor necrosis factor α (TNF-α) agent approved for the treatment of ankylosing spondylitis (AS); psoriatic arthritis; an...